BioSpace News Archive

Drug Development

MRI Contrast Agents Go Head-to-Head: Researchers Find Greater Morphologic Information and Lesion Enhancement with Bracco Diagnostics Inc.’s MultiHance® (gadobenate dimeglumine) Injection, 529 mg/mL When Compared to Gadavist™ (gadobutrol injection)

March 7, 2012
·
1 min read
BioMidwest

Abbott Laboratories to Present at Barclays Capital 2012 Global Healthcare Conference

March 7, 2012
·
1 min read
Business

Chelsea Therapeutics, Inc. Reports Fourth Quarter and Full Year 2011 Results

March 7, 2012
·
1 min read
Drug Development

Isis Pharmaceuticals, Inc. Initiates Phase 1 Study in Patients With Cancer With the First Generation 2.5 Antisense Drug, ISIS-STAT3Rx

March 7, 2012
·
4 min read
Deals

Amgen Completes Tender Offer for Outstanding Shares of Micromet

March 7, 2012
·
5 min read
Pharm Country

Sanofi-Aventis U.S. LLC. Release: Survey Reveals a Majority of Cancer Patients, Survivors Are Unaware of Higher Risk for Developing Deep-Vein Thrombosis and Pulmonary Embolism

March 7, 2012
·
5 min read
BioMidwest

Stryker Launches Next Generation Heavy Duty Surgical Power Tools

March 7, 2012
·
2 min read
BioCapital

GenVec Inc. to Release Fourth Quarter and Year-End 2011 Financial Results and Conduct a Conference Call on March 15, 2012

March 7, 2012
·
1 min read
Bio NC

STEM CELLS Translational Medicine Release: Stem Cell-Seeded Cardiopatch Could Deliver Results for Damaged Hearts

March 7, 2012
·
3 min read
Drug Development

Fourteenth Patient Dosed in NeuralStem Inc. ALS Stem Cell Trial

March 7, 2012
·
3 min read